Business Segments Cencora, Inc. Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG 02:05:15 2026-09-28 EDT			5-day change	1st Jan Change
266.80 ^EUR	-1.84%		-0.04%	-15.17%

09-25	Cencora, Inc. Announces Appointment of Robert E. Sanchez as Independent Director, Effective October 1, 2026	CI
09-25	Cencora Elects Ryder Systems' Robert Sanchez to Board	MT

Breakdown by Business Segment (USD)

Fiscal Period: September	2021	2022	2023	2024	2025
Pharmaceutical Product Distribution
U.S. Healthcare Solutions	-	212B	235B	265B	291B
CAPEX	-	-	-268M	-274M	-400M
Gross Profit	-	5.45B	5.82B	6.42B	7.91B
D&A	-	-	293M	299M	353M
Operating Income	-	2.46B	2.6B	2.93B	3.57B
	-	-	-	-	30.37B
International Healthcare Solutions	-	26.49B	27.42B	28.63B	30.37B
CAPEX	-	-	-190M	-213M	-268M
Gross Profit	-	2.95B	3.19B	3.32B	3.32B
D&A	-	-	120M	133M	145M
Operating Income	-	706M	693M	713M	648M
Other	15.97B	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-176M	-	-	-	-
Gross Profit	2.29B	-	-	-	-
D&A	118M	-	-	-	-
Operating Income	615M	-	-	-	-
	-	-	-	-	291B
Pharmaceutical Distribution Services	198B	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-262M	-	-	-	-
Gross Profit	4.29B	-	-	-	-
D&A	210M	-	-	-	-
Operating Income	2.04B	-	-	-	-
Corporate	-	-	-	-	-
Gross Profit	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Intersegment Eliminations	-139M	-4.87M	-4.49M	-8.37M	-15.53M
Gross Profit	-10.61M	-189K	-	-3.05M	-5.9M
Operating Income	-7.84M	-	-	-	-
Gross Profit	203M	-67.17M	-205M	52.17M	76.88M
Operating Income	203M	-67.17M	-205M	52.17M	76.88M
D&A	176M	-	551M	660M	553M

Geographical breakdown of sales (USD)

Fiscal Period: September	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025